$EDXC Begins Shipment of Third Eye Chai CBD-Infused Gourmet Tea Beverages

Endexx Begins Shipment of Third Eye Chai CBD-Infused Gourmet Tea Beverages

BUZ INVESTORS Third Eye Chai CBD-Infused Endexx Corporation ( OTC PINK : EDXC ), a provider of innovative phytonutrient

Endexx’s first product launch Third Eye Chai™, a masala chai tea, was a result of its license and distribution deal with The Mad Hatter Coffee & Tea Co. The collaboration offers a major opportunity to bring specific hemp and CBD-infused natural blends to the global health and whole foods markets, a major step for the cross-over markets valued at over $3 billion.




Third Eye Chai CBD-Infused

READ  Invictus MD prepares for legalization with expected cannabis ready production of 6,000 kg
READ  American Cannabis Company, Inc. AMMJ Announces It Has Secured A Contract With A New Client In Ohio
READ  Tetra Bio-Pharma Announces Approval to List on the TSX Venture Exchange

Todd Davis, CEO of Endexx, stated, “Our CBD-infused Chai, is primarily a wellness product that contains only the finest tea and herb ingredients and provides our customers with an enhanced tea experience. Although there is still a lot of education to be done on the health benefits of CBD, it has been proven to alleviate inflammation, muscle spasms, anxiety, epileptic seizures, and pain. Our licensing and partnership agreement with The Mad Hatter Coffee & Tea Co., will initially allow us to distribute our tea in the US, following with global distribution. This first product launch enables Endexx to generate licensing agreements with several large family owned conglomerates and distributors that have expressed strong interest in licensing our products, providing for additional revenue opportunities.”

About Endexx
Endexx provides innovative inventory management and technology solutions. Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites®, is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 — the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and an “End of Sale” technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The Autospense™ is a commercial grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites include: www.cbdunlimited.com, www.endexx.com, www.m3hub.com.

Like up on FACEBOOK


Ebates Coupons and Cash Back



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Click here for reuse options!
Copyright 2017 Investors Buz

Jadtecnic

Richard Dambrosi (JADTECNIC) Has Been Sharing FOREX INVESTORS ANALYSIS FORECAST since 2011. Editors and Founder of InvestorsBuz.com, has a passion for Forex Social Sharing analysis and Market Trends Such as Self Driving Cars, Electric Cars, Medical Marijuana, 3d printing and Cloud computing, Refers to Readers as BUZ INVESTORS.

Leave a Reply

Create Account



Log In Your Account